Zerweck Leonie, Klose Uwe, Würtemberger Urs, Richter Vivien, Nägele Thomas, Gohla Georg, Grundmann-Hauser Kathrin, Estler Arne, Ruff Christer, Erb Gunter, Ernemann Ulrike, Hauser Till-Karsten
Department of Diagnostic and Interventional Neuroradiology, University Hospital Tuebingen, 72076 Tuebingen, Germany.
Department of Neuroradiology, Medical Center, Faculty of Medicine, University of Freiburg, 79106 Freiburg im Breisgau, Germany.
Diagnostics (Basel). 2025 Feb 21;15(5):532. doi: 10.3390/diagnostics15050532.
: The non-invasive identification of glioma subtypes is useful for initial diagnosis, treatment planning, and follow-up. The aim of this study was to evaluate the performance of diffusion kurtosis imaging (DKI) and dynamic contrast-enhanced (DCE)-MRI in differentiating subtypes of adult-type diffuse gliomas. : In a prospective multicenter study, standardized MRI was analyzed in 59 patients with adult-type diffuse glioma. DKI and DCE-MRI parameter values were quantitatively evaluated in ROIs of contrast-enhancing/solid tumor and four concentric shells of peritumoral tissue. The parameter means of glioblastomas, IDH wildtype; astrocytomas, IDH mutant; and oligodendrogliomas, IDH mutant were compared. Binary logistic regression analyses were performed to differentiate between IDH mutant and IDH wildtype gliomas and between IDH mutant astrocytomas and oligodendrogliomas. ROC curves were analyzed for each parameter and for combined regression. : Significant differences between the three aforementioned subtypes were found for the DKI and DCE-MRI parameters, depending on the distance to the tumor core. A combination of the parameters' apparent diffusion coefficient (ADC) and fractional volume of extravascular extracellular space (ve) revealed the best prediction of IDH mutant vs. wildtype gliomas (AUC = 0.976 (0.943-1.000)) and astrocytomas vs. oligodendrogliomas (AUC = 0.840 (0.645-1.000)) with the lowest Akaike information criterion. : The combined evaluation of DKI and DCE-MRI at different distances to the contrast-enhancing/solid tumor seems to be helpful in predicting glioma subtypes according to the WHO 2021 classification.
成人型弥漫性胶质瘤亚型的无创识别对于初始诊断、治疗规划和随访很有用。本研究的目的是评估扩散峰度成像(DKI)和动态对比增强(DCE)-MRI在鉴别成人型弥漫性胶质瘤亚型方面的性能。
在一项前瞻性多中心研究中,对59例成人型弥漫性胶质瘤患者的标准化MRI进行了分析。在对比增强/实性肿瘤的感兴趣区(ROI)和瘤周组织的四个同心壳层中定量评估DKI和DCE-MRI参数值。比较了胶质母细胞瘤(IDH野生型)、星形细胞瘤(IDH突变型)和少突胶质细胞瘤(IDH突变型)的参数均值。进行二元逻辑回归分析以区分IDH突变型和IDH野生型胶质瘤,以及IDH突变型星形细胞瘤和少突胶质细胞瘤。分析了每个参数和联合回归的ROC曲线。
根据与肿瘤核心的距离,上述三种亚型在DKI和DCE-MRI参数上存在显著差异。参数表观扩散系数(ADC)和血管外细胞外间隙分数体积(ve)的组合显示,对IDH突变型与野生型胶质瘤(AUC = 0.976(0.943 - 1.000))以及星形细胞瘤与少突胶质细胞瘤(AUC = 0.840(0.645 - 1.000))的预测效果最佳,且赤池信息准则最低。
根据世界卫生组织2021年分类,在不同距离的对比增强/实性肿瘤处联合评估DKI和DCE-MRI似乎有助于预测胶质瘤亚型。